Privia Health Group (PRVA) Q2 FY2025 earnings: revenue $521 million, up 23.4% on the year

Privia Health Group, Inc. (PRVA) reported revenue of $521 million for Q2 FY2025, the quarter ended 30 June 2025, up 23.4% on the same quarter a year earlier. Net income was $3 million, down 22.5% on the year, and diluted earnings per share $0.02. The figures are the company's own, from the 10-Q it filed with the SEC on 7 August 2025.

Revenue$521 millionup 23.4%

Net income$3 milliondown 22.5%

Diluted EPS$0.02

QuarterQ2 FY2025ended 30 June 2025

The quarter, against the one before and a year earlier

Line	Q2 FY2025	Q1 FY2025	Q2 FY2024	Change on the year
Revenue	521	480	422	+23.4%
Operating income	3.3	5.2	5.1	-34.6%
Operating margin	0.6%	1.1%	1.2%
Pre-tax income	5.7	8.1	8.1	-28.8%
Income tax	2.5	2.1	3.4	-28.2%
Effective tax rate	42.8%	25.8%	42.4%
Net income	2.7	4.2	3.5	-22.5%
Net margin	0.5%	0.9%	0.8%
Diluted EPS	$0.02	$0.03	$0.03	-33.3%

$ million except per share.

Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow and capital returned

Line	Q2 FY2025	Q1 FY2025	Q2 FY2024	Change on the year
Operating cash flow	8.0	-24.1	34.5	-76.9%
Cash from investing	-89.1	0.0	0.0	n/a
Cash from financing	1.9	2.2	1.7	+7.7%
Depreciation and amortisation	2.6	1.9	1.8	+42.1%
Share-based compensation	18.8	17.8	14.4	+31.0%
Diluted shares, weighted	128m	128m	125m	+2.5%
Shares outstanding at period end	123m	121m	119m	+2.7%

Cash flow lines for the quarter; where the company files them year to date, the quarter is the difference between two filings.

Balance sheet at quarter end

Line	Q2 FY2025	Q1 FY2025	Q2 FY2024	Change on the year
Shareholders' equity	683	659	595	+14.7%
Non-controlling interest	50.7	50.1	48.2	+5.2%
Debt	0.0	0.0	0.0	n/a
Operating lease liabilities	4.1	3.0	4.1	+0.8%
Other liabilities	535	471	430	+24.4%
Total liabilities and equity	1,273	1,184	1,078	+18.1%
Fixed assets	0.8	1.0	1.7	-52.7%
Goodwill	172	142	139	+23.5%
Intangible assets	170	108	105	+62.7%
Cash and equivalents	390	469	387	+0.7%
Receivables	444	389	370	+20.0%
Other assets	95.2	74.7	74.4	+28.0%
Total assets	1,273	1,184	1,078	+18.1%

Questions

What was Privia Health Group's revenue in Q2 FY2025?

Privia Health Group (PRVA) reported revenue of $521 million for Q2 FY2025, the quarter ended 30 June 2025, up 23.4% on the same quarter a year earlier.

How much did Privia Health Group earn in Q2 FY2025?

Net income for Q2 FY2025 was $3 million, down 22.5% on the year, and diluted earnings per share $0.02.

When did Privia Health Group report Q2 FY2025 results?

Privia Health Group filed its 10-Q for the quarter ended 30 June 2025 with the SEC on 7 August 2025.

Quarterly results, the last 12 quarters

	Q3 FY2023	Q4 FY2023 *	Q1 FY2024	Q2 FY2024	Q3 FY2024	Q4 FY2024 *	Q1 FY2025	Q2 FY2025	Q3 FY2025	Q4 FY2025 *	Q1 FY2026	Q2 FY2026
Revenue	417	441	415	422	438	461	480	521	580	541	604	633
Operating income	5.5	1.4	0.8	5.1	5.8	5.2	5.2	3.3	14.4	11.3	7.4	11.8
Operating margin	1%	0%	0%	1%	1%	1%	1%	1%	2%	2%	1%	2%
Pre-tax income	8.4	4.3	3.8	8.1	8.0	8.0	8.1	5.7	16.7	13.4	9.3	16.8
Tax rate	30%	46%	20%	42%	50%	33%	26%	43%	41%	21%	60%	42%
Net income	5.6	2.8	3.0	3.5	3.5	4.4	4.2	2.7	6.9	9.2	3.1	9.0
Net margin	1%	1%	1%	1%	1%	1%	1%	1%	1%	2%	1%	1%
Diluted EPS	$0.05	$0.02	$0.02	$0.03	$0.03	$0.03	$0.03	$0.02	$0.05	$0.07	$0.02	$0.07
Operating cash flow	22.5	64.1	-33.1	34.5	33.2	74.8	-24.1	8.0	52.0	128	-49.5	1.1
Capital expenditure	0.0	0.0	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Free cash flow	22.4	64.1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares outstanding	118m	118m	119m	119m	120m	120m	121m	123m	123m	124m	126m	126m
Filing	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K	10-Q	10-Q

Each quarter as filed, linked to its filing.

* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS and diluted share count are from the company's results press release for that quarter, used where the release gives the same revenue and net income as the table. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Source

10-Q for the period ended 30 June 2025, filed 7 August 2025, accession 0001759655-25-000093: the filing on EDGAR. All of Privia Health Group, Inc.'s filings: EDGAR company page.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install